CDK6 and acute myeloid leukemia: To accomplish this, we conducted an analysis on data obtained from Gene Expression Omnibus (GEO) (Barrett et al., 2013), Oncomine (Rhodes et al., 2004), and The Cancer Genome Atlas (TCGA) database (Weinstein et al., 2013) and found that CDK6 is overexpressed in AML patients.